Topical treatment of pyogenic granulomas in a pediatric population: A single-institution retrospective review
Kelly K. Barry, Marilyn G. Liang, Elena B. Hawryluk
Abstract
To the Editor: Pyogenic granulomas (PG) are common benign vascular proliferations of the skin and mucous membranes. Because of their propensity to grow and bleed, surgical management is favored, but it can be costly, traumatic, result in scarring, or require an in-office or operative suite setting. Noninvasive treatment modalities include topical beta-blockers,1 imiquimod,2 and corticosteroids.3 By promoting vasoconstriction and downregulating proangiogenic factors such as vascular endothelial growth factor A, matrix metalloproteinase 1, and interleukin 6, topical corticosteroids potentially target several key pathways implicated in the PG pathogenesis.
Topics & Concepts
Pyogenic granulomaMedicineImiquimodDermatologyPyoderma gangrenosumTopical steroidPopulationPathologyLesionDiseaseEnvironmental healthVascular Malformations and HemangiomasVascular Tumors and AngiosarcomasUrologic and reproductive health conditions